Literature DB >> 19634902

Univalent and bivalent ligands of butorphan: characteristics of the linking chain determine the affinity and potency of such opioid ligands.

Michael Decker1, Brian S Fulton, Bin Zhang, Brian I Knapp, Jean M Bidlack, John L Neumeyer.   

Abstract

Bivalent morphinan compounds containing ester linkers were synthesized and their binding affinities at the mu, delta, and kappa opioid receptors determined. Addition of methyl groups adjacent to the hydrolytically labile ester linkage increased stability while only partially affecting binding affinity. The resulting bivalent ligands with optimized spacer length and structure show potent binding profiles with the most potent compound (4b), having K(i) values of 0.47 nM for both the mu and kappa opioid receptors, and 4a, having K(i) values of 0.95 and 0.62 nM for the mu and kappa receptors, respectively. Both 4a and 4b were partial agonists at the kappa and micro receptors in the [(35)S]GTPgammaS binding assay.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19634902      PMCID: PMC2788666          DOI: 10.1021/jm900379p

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  14 in total

1.  Mixed kappa agonists and mu agonists/antagonists as potential pharmacotherapeutics for cocaine abuse: synthesis and opioid receptor binding affinity of N-substituted derivatives of morphinan.

Authors:  J L Neumeyer; X H Gu; L A van Vliet; N J DeNunzio; D E Rusovici; D J Cohen; S S Negus; N K Mello; J M Bidlack
Journal:  Bioorg Med Chem Lett       Date:  2001-10-22       Impact factor: 2.823

2.  Effects of kappa opioids on cocaine self-administration by rhesus monkeys.

Authors:  S S Negus; N K Mello; P S Portoghese; C E Lin
Journal:  J Pharmacol Exp Ther       Date:  1997-07       Impact factor: 4.030

3.  Synthesis and opioid receptor affinity of morphinan and benzomorphan derivatives: mixed kappa agonists and mu agonists/antagonists as potential pharmacotherapeutics for cocaine dependence.

Authors:  J L Neumeyer; J M Bidlack; R Zong; V Bakthavachalam; P Gao; D J Cohen; S S Negus; N K Mello
Journal:  J Med Chem       Date:  2000-01-13       Impact factor: 7.446

4.  Tetrabutylammonium fluoride-mediated rapid alkylation reaction in microtiter plates for the discovery of enzyme inhibitors in situ.

Authors:  Chung-Yi Wu; Ashraf Brik; Sheng-Kai Wang; Yu-Hsien Chen; Chi-Huey Wong
Journal:  Chembiochem       Date:  2005-12       Impact factor: 3.164

5.  Synthesis and preliminary in vitro investigation of bivalent ligands containing homo- and heterodimeric pharmacophores at mu, delta, and kappa opioid receptors.

Authors:  Xuemei Peng; Brian I Knapp; Jean M Bidlack; John L Neumeyer
Journal:  J Med Chem       Date:  2006-01-12       Impact factor: 7.446

6.  Pharmacological properties of bivalent ligands containing butorphan linked to nalbuphine, naltrexone, and naloxone at mu, delta, and kappa opioid receptors.

Authors:  Xuemei Peng; Brian I Knapp; Jean M Bidlack; John L Neumeyer
Journal:  J Med Chem       Date:  2007-04-04       Impact factor: 7.446

Review 7.  Kappa receptor bivalent ligands.

Authors:  Xuemei Peng; John L Neumeyer
Journal:  Curr Top Med Chem       Date:  2007       Impact factor: 3.295

8.  Several delta-opioid receptor ligands display no subtype selectivity to the human delta-opioid receptor.

Authors:  Amy L Parkhill; Jean M Bidlack
Journal:  Eur J Pharmacol       Date:  2002-09-20       Impact factor: 4.432

9.  Effects of kappa opioid agonists on cocaine- and food-maintained responding by rhesus monkeys.

Authors:  N K Mello; S S Negus
Journal:  J Pharmacol Exp Ther       Date:  1998-08       Impact factor: 4.030

10.  Cyclopropanecarboxylic acid esters as potential prodrugs with enhanced hydrolytic stability.

Authors:  David M Bender; Jeffrey A Peterson; James R McCarthy; Hakan Gunaydin; Yu Takano; K N Houk
Journal:  Org Lett       Date:  2008-01-09       Impact factor: 6.005

View more
  6 in total

1.  Synthesis and binding affinity of novel mono- and bivalent morphinan ligands for κ, μ, and δ opioid receptors.

Authors:  Bin Zhang; Tangzhi Zhang; Anna W Sromek; Thomas Scrimale; Jean M Bidlack; John L Neumeyer
Journal:  Bioorg Med Chem       Date:  2011-03-26       Impact factor: 3.641

2.  Effect of linker substitution on the binding of butorphan univalent and bivalent ligands to opioid receptors.

Authors:  Brian S Fulton; Brian L Knapp; Jean M Bidlack; John L Neumeyer
Journal:  Bioorg Med Chem Lett       Date:  2010-01-25       Impact factor: 2.823

3.  Opioid bifunctional ligands from morphine and the opioid pharmacophore Dmt-Tic.

Authors:  Gianfranco Balboni; Severo Salvadori; Ewa D Marczak; Brian I Knapp; Jean M Bidlack; Lawrence H Lazarus; Xuemei Peng; Yu Gui Si; John L Neumeyer
Journal:  Eur J Med Chem       Date:  2010-12-08       Impact factor: 6.514

Review 4.  Biased, Bitopic, Opioid-Adrenergic Tethered Compounds May Improve Specificity, Lower Dosage and Enhance Agonist or Antagonist Function with Reduced Risk of Tolerance and Addiction.

Authors:  Robert Root-Bernstein
Journal:  Pharmaceuticals (Basel)       Date:  2022-02-10

5.  Pharmacological Profiles of Oligomerized μ-Opioid Receptors.

Authors:  Cynthia Wei-Sheng Lee; Ing-Kang Ho
Journal:  Cells       Date:  2013-10-11       Impact factor: 6.600

6.  A facile synthesis for novel loperamide analogs as potential μ opioid receptor agonists.

Authors:  Xiaofeng Bao; Duliang Liu; Yanyan Jin; Yao Yang
Journal:  Molecules       Date:  2012-12-03       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.